HCM
BLACR

Highbridge Capital Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History

Highbridge Capital Management’s Portfolio BLACR Stock Details BLACR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
2024
Q4 		$100K Hold
2024
Q3 		$87.2K Hold
2024
Q2 		$92.9K Hold
2024
Q1 		$125K Hold
2023
Q4 		$125K Buy
2023
Q3 		$206K Hold
2023
Q2 		$169K Buy
2023
Q1 		$104K Buy